Posts tagged as

COMPPARE

COMPPARE Enrolls 1,500th Proton Patient, Reaches Cohort Goal

The COMPPARE Coordinating Center announced today that the study has enrolled its 1,500th proton prostate cancer patient and has closed enrollment for the proton cohort. This goal was achieved in advance of the projected completion date of July 31, 2022. The proton cohort is divided into two groups: Pragmatic and…

COMPPARE Achieves 75% Enrollment Milestone

The COMPPARE Coordinating Center announced today that the study achieved 75% enrollment on May 3, 2022. COMPPARE realized both a remarkable overall accrual rate and a exceptional accrual rate of minorities, despite the ongoing challenges presented by COVID-19. In fact, the study stands to become a model for patient-centric clinical…

A Look at the New Technology Known as Theranostics

Brotherhood of the Balloon, a COMPPARE Partner Organization, reports on a new technology known as theranostics in the latest BOBtales newsletter. This approach combines molecular therapies (therapy) and paired molecular targeted imaging (diagnostics). In theranostics, a special diagnostic molecule is first…

COMPPARE Newsletter: Fall/Winter 2021-22

A Message from Dr. Nancy Mendenhall Our focus on IMRT enrollment has increased as we have become more aware of practice pattern changes that have impacted IMRT accrual, specifically the increased utilization of ultra-hypofractionated radiation (stereotactic body radiation therapy, or SBRT). Read Dr. Mendenhall’s message.

From Principles to Practice: Building Partnerships for Trust and Equity in Health Research with COMPPARE

On November 17, Dr. Nancy Mendenhall, COMPPARE Principal Investigator, and Charles Griggs, Minority Engagement Group Coordinator, participated in a special panel discussion entitled “From Principles to Practice: Building Partnerships for Trust and Equity in Health Research” during the 7th annual meeting of the Patient-Centered Outcomes Research Institute (PCORI). “This year’s…

COMPPARE Reaches Its Pragmatic Proton Patient Enrollment Goal

The COMPPARE Coordinating Center announced on September 1, 2021 that the study had reached its Pragmatic Proton enrollment goal of 900 patients, completing and closing that arm of the proton cohort. The 900th patient was enrolled by the Proton Therapy Treatment & Research Center of the Loma Linda University Medical…

COMPPARE Consortium Spotlight: The Hampton University Proton Therapy Institute

Recently celebrating ten years in operation, Hampton University Proton Therapy Institute (HUPTI) has treated more than 3,100 patients to date and is the largest free-standing proton therapy cancer center in the world. HUPTI has also led most COMPPARE partner sites in patient enrollment over the past year, with plans…